Shawn Kumar, Founder and CEO of RhythmScience, expressed his excitement about the partnership, stating, "We are thrilled to partner with MedAxiom, the epitome of excellence in the cardiovascular community. Our collaboration with MedAxiom will enable us to further enhance the management of patients with chronic cardiovascular conditions and simplify remote cardiology. Together, we will drive innovation, improve patient outcomes, and shape the future of cardiac care."

RhythmScience has been committed to empowering physicians and their clinical teams by providing cutting-edge tools to unlock the power of cardiac data and enhance patient care. Through its comprehensive data platform, Rhythm360, RhythmScience offers a longitudinal view of multiple disease states, including hypertension, heart failure, and cardiac rhythm disorders, streamlining workflows and promoting efficient collaboration. Now, with the partnership with MedAxiom, RhythmScience is poised to achieve even greater success in its mission.

"MedAxiom has always been focused on fostering a community where new ideas and data can be shared, with the goal of transforming cardiovascular care. We are excited to welcome RhythmScience to the community as they help to address the complex challenge of unifying patient data in one place to better inform clinical decisions more efficiently throughout care delivery," said Joe Sasson, PhD, MedAxiom's EVP of Ventures and chief commercial officer.

The partnership with MedAxiom will provide RhythmScience with invaluable industry resources and insights, enabling them to expand their footprint in the large market for cardiac data. RhythmScience's comprehensive services and innovative technology, combined with MedAxiom's expertise and vast network, will contribute to better healthcare delivery and patient care across the cardiovascular landscape.